RIVA, BEATRICE
 Distribuzione geografica
Continente #
EU - Europa 737
NA - Nord America 615
AS - Asia 159
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.514
Nazione #
US - Stati Uniti d'America 605
IT - Italia 231
IE - Irlanda 196
DE - Germania 99
SE - Svezia 87
UA - Ucraina 48
HK - Hong Kong 38
SG - Singapore 31
CN - Cina 30
IN - India 28
FR - Francia 19
BE - Belgio 17
GB - Regno Unito 17
TR - Turchia 13
CA - Canada 10
FI - Finlandia 10
VN - Vietnam 10
IR - Iran 7
CZ - Repubblica Ceca 5
NL - Olanda 4
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
NG - Nigeria 1
RU - Federazione Russa 1
Totale 1.514
Città #
Dublin 193
Jacksonville 92
Chandler 81
Ann Arbor 67
Piemonte 53
Hong Kong 38
Wilmington 28
Dearborn 25
Bremen 20
Lawrence 20
Princeton 20
Milan 19
Munich 18
Novara 18
Singapore 18
Ashburn 17
Beijing 17
Strasbourg 17
Turin 17
San Mateo 16
Brussels 15
Dong Ket 10
Dallas 9
Kocaeli 9
Toronto 7
Andover 6
Torino 6
Asti 5
Boardman 5
Brno 5
Cassano Magnago 5
Woodbridge 5
Biella 4
Cagliari 4
Como 4
Helsinki 4
Moncalieri 4
Mülheim 4
Norwalk 4
Seattle 4
Zanjan 4
Bologna 3
Cambridge 3
Castelnuovo Bormida 3
Imola 3
Ipswich 3
Monmouth Junction 3
Sacramento 3
Santa Clara 3
Vercelli 3
Zola Predosa 3
Alagna Valsesia 2
Augusta 2
Bari 2
Brescia 2
Cureggio 2
Frankfurt am Main 2
Hefei 2
Houston 2
Nijmegen 2
Noicattaro 2
San Francisco 2
Waanrode 2
Winnipeg 2
Wustrow 2
Ardabil 1
Bengaluru 1
Borås 1
Busto Arsizio 1
Cachan 1
Cesano Maderno 1
Chengdu 1
Chiavari 1
Des Moines 1
Fairfield 1
Falkenstein 1
Florence 1
Grafing 1
Grosseto 1
Guangdong 1
Henderson 1
Hummelstown 1
Jiaxing 1
Jinan 1
Kunming 1
Lagos 1
Maccacari 1
Monza 1
Nanchang 1
Nanjing 1
Odalengo Grande 1
Omegna 1
Ottawa 1
Paris 1
Pusan 1
Rho 1
Rivoli 1
Saarbrücken 1
San Diego 1
Tianjin 1
Totale 1.010
Nome #
Celecoxib targets CML blasts proliferation in a COX-2 independent manner 151
Preparation of 1-​(triazolylphenyl)​-​5-​(trifluoromethyl)​pyrazole compounds useful as SOCE modulators 102
A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy. 99
Dissecting the Mechanism of Action of Spiperone— A Candidate for Drug Repurposing for Colorectal Cancer 97
Contribution of hyperpolarizing ion channels to acute cold hypersensitivity induced by oxaliplatin administration 80
Oxaliplatin-induced cytosolic acidification alters TRP and K2P channel activity in sensory neurons 78
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 77
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 74
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 70
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 67
A novel gain-of-function mutation in ORAI1 causes late-onset tubular aggregate myopathy and congenital miosis 66
SiO2nanoparticles modulate the electrical activity of neuroendocrine cells without exerting genomic effects 62
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 61
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry 61
Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification 58
Characterization of a functional Ca2+ toolkit in urine-derived stem cells and derived skeletal muscle cells 55
Calcium-related Neurotoxicity of Oxaliplatin: Understanding the Mechanisms to Drive Therapy 53
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 51
Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors 51
Unexpected Ca2+-mobilization of oxaliplatin via H1 histamine receptors 47
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 35
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy 30
STIM1 and ORAI1 mutations leading to tubular aggregate myopathies are sensitive to the Store-operated Ca2+-entry modulators CIC-37 and CIC-39 28
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 12
Totale 1.565
Categoria #
all - tutte 7.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 0 0 1 18 18 43 4 19 31 28 1
2020/2021228 24 11 20 10 24 16 20 21 22 25 19 16
2021/2022236 19 23 17 20 7 4 10 10 15 34 32 45
2022/2023581 49 24 34 21 61 61 25 30 230 9 28 9
2023/2024176 17 11 17 5 23 4 48 12 1 1 17 20
2024/202566 19 16 20 11 0 0 0 0 0 0 0 0
Totale 1.565